Interesting Tony, and shows the diversity even with immunology. Our recent announcement was regarding targetting Cross presenting dendritic cells, part of the immune system, and getting the immune system to attack the cancer cells.
The article refers to slightly different approach in targetting a molecule on the surface of cancer cell itself, then seemingly causing he cancer cell to self destruct.
Interesting to see even at this stage there is more than 1 way to kill the cancer??
Also interesting all seem to require the ability to enter cells. The downside I guess is if others are as advanced as it is then maybe cell penetration isn' such a big deal??
Interesting Tony, and shows the diversity even with immunology....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |